menu search

Rain, ptra, btai, class action update: johnson fistel alerts shareholders of ongoing legal proceedings

SAN DIEGO, Aug. 04, 2023 (GLOBE NEWSWIRE) — Johnson Fistel, LLP, a law firm specializing in shareholder rights, has announced the ...

August 4, 2023, 2:08 pm

Beacon (becn) beats on q2 earnings & revenues, ups 2023 view

Beacon's (BECN) second-quarter 2023 results benefit from strong residential demand and the Ambition 2025 initi...

August 4, 2023, 1:32 pm

Larimar: friedreich's ataxia drug with significant potential

Clearance given by FDA to initiate higher 50 mg dosing of CTI-1601 for patients with Friedreich's Ataxia for phase 2 study; results from this cohort e...

August 2, 2023, 6:02 am

Altimmune announces initiation of phase 2b impact trial evaluating the efficacy and safety of pemvidutide in non-alcoholic steatohepatitis (nash)

GAITHERSBURG, Md., Aug. 01, 2023 (GLOBE NEWSWIRE) — Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that ...

August 1, 2023, 11:30 am

5 crypto stocks in focus after fed's rate hike reinitiation

A financial advisor can help you understand the advantages and disadvantages of investment properties....

July 29, 2023, 2:12 am

5 crypto stocks in focus after fed's rate hike reinitiation

We have narrowed our search to five stocks with solid crypto exposure. These Are: NVDA, PYPL, SQ, ACN, IBKR....

July 28, 2023, 9:30 am

Newmark group: watch out for potential catalysts (rating upgrade)

One potential catalyst for NMRK is the initiation of share buybacks in time to come, which is likely co...

July 17, 2023, 1:42 pm

Viridian: despite drop, advancement towards phase 3 continues

There were positive results achieved from Viridian Therapeutics, Inc. phase 1/2 study using VRDN-001 for the treatment of patients with chronic thyroi...

July 13, 2023, 3:16 pm

Biolinerx: pdufa catalyst and pdac advancement make this worth a look

A PDUFA date of September 9, 2023 has been established for review of Motixafortide for Autologous Transplantation in Multiple Myeloma. Results from a ...

July 10, 2023, 7:36 pm

Mannkind shares fall after fire that may delay clinical trial

Shares of MannKind Corp. MNKD, +2.78% fell 1.5% premarket on Monday after the biopharma company said a fire at a German manufacturing facility may del...

July 3, 2023, 8:27 am

Sofi technologies: rally was overdone

SoFi Technologies has seen its shares rise by more than 80% in 2023, but a recent "Sell" initiation by ...

June 24, 2023, 7:39 am

Sofi stock price prediction: is sofi really worth just $5?

SoFi (NASDAQ: SOFI ) stock is lower by more than 5% today following the initiation of coverage by Compa...

June 23, 2023, 11:20 am

Why tigo energy stock was surging this week

The niche solar energy solutions provider experienced a rare double initiation of coverage from two ana...

June 23, 2023, 9:49 am

Johnson fistel urges shareholders to seek legal counsel for class action lawsuits against atlas lithium, sentinelone, and dzs

SAN DIEGO, June 20, 2023 (GLOBE NEWSWIRE) — Johnson Fistel, LLP, a law firm specializing in shareholder rights, has announced the ...

June 20, 2023, 5:57 pm

Wall street giants propel edx markets into digital asset trading scene

EDX Markets, a new digital asset marketplace, has announced the successful initiation of its trading op...

June 20, 2023, 5:37 pm

Nls pharmaceutics announces company update webcast

Members of Executive Leadership Team to Discuss initiation of Phase 3, Pipeline updates, Key Financials...

June 19, 2023, 7:10 am

Nls pharmaceutics announces company update webcast

Members of Executive Leadership Team to Discuss initiation of Phase 3, Pipeline updates, Key Financials...

June 15, 2023, 7:30 am

Ventyx biosciences announces initiation of dosing in a phase 1 trial of vtx3232, a novel cns-penetrant nlrp3 inhibitor

Topline data from the Phase 1 SAD/MAD trial of VTX3232 are expected in H1 2024 ENCINITAS, Calif., June 14, 2023 (GLOBE NEWSWIRE) — Ventyx Bioscience...

June 14, 2023, 11:00 am

Remitly global: on track for profitable growth

RELY continues to show strong growth and profitability in the cross-border remittance market, with its mobile-first approach driving customer satisfac...

June 6, 2023, 9:44 am


Search within

Pages Search Results: